This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Acadia Healthcare (ACHC) Q3 Earnings Meet Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 results reflect higher revenues, driven by solid demand for its behavioral health services and higher admissions.
4 Hospital Stocks to Gain From Rebounding Patient Volumes
by Zacks Equity Research
Expanding patient volumes, use of telehealth services, cost-control measures and an aging demography are tailwinds to the hospital industry players like HCA, UHS, THC and ACHC.
Universal Health (UHS) Q3 Earnings Miss Mark, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect high expenses, partly offset by better revenues.
Company News for Oct 26, 2021
by Zacks Equity Research
Companies in The News Are: KMB,UHS,CBU,AUB
Universal Health Services (UHS) Q3 Earnings Lag Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of -4.30% and 0.01%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Universal Health's (UHS) Q3 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q3 earnings are likely to have suffered elevated costs, partly offset by better patient volumes.
Earnings Preview: Universal Health Services (UHS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Acquires to Expand in Texas & Idaho
by Zacks Equity Research
Ensign Group (ENSG) establishes dominance in the Texas and Idaho markets with further buyouts.
Here's Why You Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is benefiting on the back of robust segmental performances and well-diversified healthcare suite. A strong partner network throughout U.S. is an added advantage.
Down 11.9% in 4 Weeks, Here's Why Universal Health Services (UHS) Looks Ripe for a Turnaround
by Zacks Equity Research
Universal Health Services (UHS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
HCA Healthcare (HCA) Up 109.5% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) cost-curbing measures, strategic initiatives and a solid guidance are likely to bump up its shares.
Teladoc (TDOC) to Offer Remote Solutions for Canada Patients
by Zacks Equity Research
Teladoc Health (TDOC) has been selected by Infoway for providing remote patient monitoring solutions throughout Canada, thereby resulting in better health conditions.
UHS vs. ACHC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UHS vs. ACHC: Which Stock Is the Better Value Option?
Here's Why You Should Retain MEDNAX (MD) in Your Portfolio
by Zacks Equity Research
Riding high on its revenue stream and strategic measures, MEDNAX (MD) holds potential to reap benefits for investors.
Here's Why You Should Buy Acadia Healthcare (ACHC) Stock Now
by Zacks Equity Research
Acadia Healthcare (ACHC) continues to gain from top-line growth, solid demand for behavioral health services, several growth-related initiatives and reducing debt levels.
Community Health (CYH) Up 136.3% in a Year: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) cost-cutting measures and strategic initiatives are likely to drive its shares higher.
UHS vs. ACHC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UHS vs. ACHC: Which Stock Is the Better Value Option?
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Backed by its strategic measures, solid segmental contributions and a strong solvency level, Universal Health (UHS) holds potential to reap benefits for investors.
Acadia Healthcare (ACHC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
Tenet Healthcare (THC) Hits 52 Week High: More Upside Left?
by Zacks Equity Research
Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it aid its upsurge.
HCA Healthcare (HCA) Hits 52 Week High: More Room for Upside?
by Zacks Equity Research
HCA Healthcare's (HCA) shares soar as investors get optimistic about its strategic initiatives and recovering volumes.
4 Hospital Stocks Likely to Perform Well in 2H21
by Debasmita Chatterjee
Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.
Universal Health Services (UHS) Down 2.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna (CI) Hikes Buyback Authorization, Boosts Shareholder Value
by Zacks Equity Research
Cigna's (CI) board raises share buyback authorization in an effort to support prudent capital deployment.